PTEN and endometrial cancer: Moreover, decreased PTEN and increased phospho‐AKT levels are more likely associated with an early event in endometrial tumorigenesis, while low expression of BMI‐1 and low level of AKT phosphorylation may be involved in endometrial cancer progression.